NVUS

Novus Therapeutics (NVUS)

Novus Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NVUS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/22	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/06/09	05 : 05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/06/05	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/23	02 : 27	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/19	06 : 16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/12	06 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/12	05 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/02	05 : 53	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/02	05 : 49	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/01	20 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/03/31	05 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	07 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	07 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	07 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/11/24	06 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/11/15	07 : 41	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/11/15	06 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/08/12	06 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/08/12	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc